Welcome!

News Feed Item

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/648928/Coronary-Vasospasm-Global-Clinical-Trials-Review-H2-2014.html

Coronary Vasospasm Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Coronary Vasospasm Global Clinical Trials Review, H2, 2014" provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Coronary Vasospasm 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Coronary Vasospasm 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Coronary Vasospasm Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Pfizer Inc. 27
Clinical Trial Overview of Pfizer Inc. 27
Clinical Trial Overview of Top Institutes / Government 28
Japanese Coronary Spasm Association 28
Clinical Trial Overview of Japanese Coronary Spasm Association 28
Robert Bosch Medical Center 29
Clinical Trial Overview of Robert Bosch Medical Center 29
Kyorin University 30
Clinical Trial Overview of Kyorin University 30
Kumamoto University 31
Clinical Trial Overview of Kumamoto University 31
National Institute of Health and Medical Research 32
Clinical Trial Overview of National Institute of Health and Medical Research 32
University of Nebraska 33
Clinical Trial Overview of University of Nebraska 33
Korea University 34
Clinical Trial Overview of Korea University 34
University Hospital Basel 35
Clinical Trial Overview of University Hospital Basel 35
Washington University School of Medicine 36
Clinical Trial Overview of Washington University School of Medicine 36
University of California, San Francisco 37
Clinical Trial Overview of University of California, San Francisco 37
Five Key Clinical Profiles 38
Appendix 55
Abbreviations 55
Definitions 55
Research Methodology 56
Secondary Research 56
About GlobalData 57
Contact Us 57
Disclaimer 57
Source 57

List of Tables
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014* 6
Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Coronary Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 12
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Coronary Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Coronary Vasospasm Therapeutics, Global, Suspended Clinical Trials, 2014* 21
Coronary Vasospasm Therapeutics, Global, Withdrawn Clinical Trials, 2014* 21
Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Coronary Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Coronary Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 27
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Coronary Spasm Association, 2014* 28
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch Medical Center, 2014* 29
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2014* 30
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014* 31
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Health and Medical Research, 2014* 32
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 33
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014* 34
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 35
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 36
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 37

List of Figures
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 13
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 16
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
GlobalData Methodology 56

Read the full report:
Coronary Vasospasm Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/648928/Coronary-Vasospasm-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Some people worry that OpenStack is more flash then substance; however, for many customers this could not be farther from the truth. No other technology equalizes the playing field between vendors while giving your internal teams better access than ever to infrastructure when they need it. In his session at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will talk through some real-world OpenStack deployments and look into the ways this can benefit customers of all sizes....
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
Due of the rise of Hadoop, many enterprises are now deploying their first small clusters of 10 to 20 servers. At this small scale, the complexity of operating the cluster looks and feels like general data center servers. It is not until the clusters scale, as they inevitably do, when the pain caused by the exponential complexity becomes apparent. We've seen this problem occur time and time again. In his session at Big Data Expo, Greg Bruno, Vice President of Engineering and co-founder of StackIQ...
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
FinTech is the sum of financial and technology, and it’s one of the fastest growing tech industries. Total global investments in FinTech almost reached $50 billion last year, but there is still a great deal of confusion over what it is and what it means – especially as it applies to retirement. Building financial startups is not simple, but with the right team, technology and an innovative approach it can be an extremely interesting domain to disrupt. FinTech heralds a financial revolution that...
In his session at DevOps Summit, Tapabrata Pal, Director of Enterprise Architecture at Capital One, will tell a story about how Capital One has embraced Agile and DevOps Security practices across the Enterprise – driven by Enterprise Architecture; bringing in Development, Operations and Information Security organizations together. Capital Ones DevOpsSec practice is based upon three "pillars" – Shift-Left, Automate Everything, Dashboard Everything. Within about three years, from 100% waterfall, C...
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
SYS-CON Media announced today that @WebRTCSummit Blog, the largest WebRTC resource in the world, has been launched. @WebRTCSummit Blog offers top articles, news stories, and blog posts from the world's well-known experts and guarantees better exposure for its authors than any other publication. @WebRTCSummit Blog can be bookmarked ▸ Here @WebRTCSummit conference site can be bookmarked ▸ Here
SYS-CON Events announced today that Addteq will exhibit at SYS-CON's @DevOpsSummit at Cloud Expo New York, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Addteq is one of the top 10 Platinum Atlassian Experts who specialize in DevOps, custom and continuous integration, automation, plugin development, and consulting for midsize and global firms. Addteq firmly believes that automation is essential for successful software releases. Addteq centers its products an...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
SYS-CON Events announced today that IoT Now has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...